0 followers
Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.
This company has no teams yet
Tessera Therapeutics
2 followers
Vaxcyte
2 followers
Artiva Biotherapeutics
1 follower
Thermo Fisher Scientific
158 followers
CRISPR Therapeutics
9 followers
Adverum Biotech
8 followers
Legend Biotech
5 followers
Verve Therapeutics
54 followers
ImmunityBio
2 followers
Johnson & Johnson
420 followers
BioAgilytix
1 follower
Explore companies